Literature DB >> 18202746

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Kirsten L Rose1, Danielle Paixao-Cavalcante, Jennifer Fish, Anthony P Manderson, Talat H Malik, Anne E Bygrave, Tao Lin, Steven H Sacks, Mark J Walport, H Terence Cook, Marina Botto, Matthew C Pickering.   

Abstract

The inflammatory kidney disease membranoproliferative glomerulonephritis type II (MPGN2) is associated with dysregulation of the alternative pathway of complement activation. MPGN2 is characterized by the presence of complement C3 along the glomerular basement membrane (GBM). Spontaneous activation of C3 through the alternative pathway is regulated by 2 plasma proteins, factor H and factor I. Deficiency of either of these regulators results in uncontrolled C3 activation, although the breakdown of activated C3 is dependent on factor I. Deficiency of factor H, but not factor I, is associated with MPGN2 in humans, pigs, and mice. To explain this discordance, mice with single or combined deficiencies of these factors were studied. MPGN2 did not develop in mice with combined factor H and I deficiency or in mice deficient in factor I alone. However, administration of a source of factor I to mice with combined factor H and factor I deficiency triggered both activated C3 fragments in plasma and GBM C3 deposition. Mouse renal transplant studies demonstrated that C3 deposited along the GBM was derived from plasma. Together, these findings provide what we believe to be the first evidence that factor I-mediated generation of activated C3 fragments in the circulation is a critical determinant for the development of MPGN2 associated with factor H deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202746      PMCID: PMC2200299          DOI: 10.1172/JCI32525

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Authors:  Aude Servais; Véronique Frémeaux-Bacchi; Moglie Lequintrec; Rémi Salomon; Jacques Blouin; Bertrand Knebelmann; Jean-Pierre Grünfeld; Philippe Lesavre; Laure-Hélène Noël; Fadi Fakhouri
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

2.  Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.

Authors:  T E Mollnes; Y C Ng; D K Peters; T Lea; J Tschopp; M Harboe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

3.  Reaction mechanism of the alternative pathway of complement fixation.

Authors:  P J Lachmann; P Nicol
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

4.  Secondary membranoproliferative glomerulonephritis.

Authors:  H G Rennke
Journal:  Kidney Int       Date:  1995-02       Impact factor: 10.612

5.  An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis.

Authors:  H K Marder; T H Coleman; J Forristal; L Beischel; C D West
Journal:  Kidney Int       Date:  1983-05       Impact factor: 10.612

6.  Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.

Authors:  Jennifer L McRae; Thomas G Duthy; Kim M Griggs; Rebecca J Ormsby; Peter J Cowan; Brett A Cromer; William J McKinstry; Michael W Parker; Brendan F Murphy; David L Gordon
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Authors:  Matthew C Pickering; H Terence Cook; Joanna Warren; Anne E Bygrave; Jill Moss; Mark J Walport; Marina Botto
Journal:  Nat Genet       Date:  2002-07-01       Impact factor: 38.330

8.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.

Authors:  K Høgåsen; J H Jansen; T E Mollnes; J Hovdenes; M Harboe
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Ontogeny of complement regulatory proteins - concentrations of factor h, factor I, c4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults.

Authors:  P F de Paula; J E Barbosa; P R Junior; V P L Ferriani; M R D O Latorre; V Nudelman; L Isaac
Journal:  Scand J Immunol       Date:  2003-11       Impact factor: 3.487

View more
  66 in total

Review 1.  C3 glomerulopathy: a new classification.

Authors:  Fadi Fakhouri; Véronique Frémeaux-Bacchi; Laure-Hélène Noël; H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

Review 2.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

3.  Eculizumab in Pediatric Dense Deposit Disease.

Authors:  Michiel J S Oosterveld; Mark R Garrelfs; Bernd Hoppe; Sandrine Florquin; Joris J T H Roelofs; L P van den Heuvel; Kerstin Amann; Jean-Claude Davin; Antonia H M Bouts; Pietrik J Schriemer; Jaap W Groothoff
Journal:  Clin J Am Soc Nephrol       Date:  2015-08-27       Impact factor: 8.237

4.  Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.

Authors:  Una Kelly; Ling Yu; Pallavi Kumar; Jin-Dong Ding; Haixiang Jiang; Gregory S Hageman; Vadim Y Arshavsky; Michael M Frank; Michael A Hauser; Catherine Bowes Rickman
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

Review 5.  Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.

Authors:  Peter F Zipfel; Richard J H Smith; Christine Skerka
Journal:  Nephrol Dial Transplant       Date:  2008-12-04       Impact factor: 5.992

6.  C5b9 Formation on Endothelial Cells Reflects Complement Defects among Patients with Renal Thrombotic Microangiopathy and Severe Hypertension.

Authors:  Sjoerd A M E G Timmermans; Myrurgia A Abdul-Hamid; Judith Potjewijd; Ruud O M F I H Theunissen; Jan G M C Damoiseaux; Chris P Reutelingsperger; Pieter van Paassen
Journal:  J Am Soc Nephrol       Date:  2018-06-01       Impact factor: 10.121

Review 7.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

8.  Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Authors:  Jennifer Laskowski; Brandon Renner; Moglie Le Quintrec; Sarah Panzer; Jonathan P Hannan; Danica Ljubanovic; Marieta M Ruseva; Dorin-Bogdan Borza; Alexandra H Antonioli; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

9.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.

Authors:  Sanjeev Sethi; Jeffrey D Gamez; Julie A Vrana; Jason D Theis; H Robert Bergen; Peter F Zipfel; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

10.  Detection of complement activation using monoclonal antibodies against C3d.

Authors:  Joshua M Thurman; Liudmila Kulik; Heather Orth; Maria Wong; Brandon Renner; Siranush A Sargsyan; Lynne M Mitchell; Dennis E Hourcade; Jonathan P Hannan; James M Kovacs; Beth Coughlin; Alex S Woodell; Matthew C Pickering; Bärbel Rohrer; V Michael Holers
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.